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A ﬁfty year old lady who was operated for thyroid cancer two years ago and completed adjuvant therapy,
underwent a computer tomography (CT) of the chest during her follow up. The CT showed a mass lesion
in the right lung, located to the lateral segment of the middle lobe. There were no intrabronchial lesions
on bronchoscopy. Positron emission CT (PET CT) showed a dense hypermetabolic mass located in the
right middle lobe lateral segment and having malignant characteristics. A videothorascopic wedge
resection was performed and the specimen was sent for frozen section, which showed no evidence of
malignancy. Pathology report revealed an inﬂammatory myoﬁbroblastic tumor (IMT). Since IMT is a rare
benign tumor of the lung, we herein report this patient along with a discussion of the relevant literature.
 2013 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Inﬂammatory myoﬁbroblastic tumor (IMT) of the lung, also
known as plasma cell granuloma or inﬂammatory pseudotumor, is
one of the rare benign tumors of the lung.1 It often occurs as a result
of excessive inﬂammatory response. A diagnosis before surgery is
difﬁcult because of the variations in radiologic appearance. Com-
plete resection is essential both for excluding malignancy and for
curative treatment.2,3 A patient who was diagnosed with IMT after
videothoracoscopic wedge resection is presented.
2. Case report
A ﬁfty year old female patient was operated two years ago for
removal of thyroid cancer, and later completed adjuvant treatment.
A routine chest CT during her follow up showed a mass in the right
middle lobe lateral segment, and the patient was referred to our
department. (Fig. 1) She was asymptomatic, and all laboratory
studies were normal. There were no pathologic ﬁndings on cranial
MRI. Respiratory function tests were within normal limits. Her
medical history revealed that she had undergone a thyroidectomycın Sok, No: 1, Mecidiyekoy,
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-NC-ND license.and cesarean section. She was using Levotron tablets once a day
since her thyroidectomy, and smoking 5e6 cigarettes a day since 15
years. Her family history was unremarkable. There were no intra-
bronchial lesions on the diagnostic bronchoscopy performed for
the investigation of endobronchial lesions. Cytologic examination
of the middle lobe lavage showed abundant bronchial and sparse
epithelial cells, alveolar macrophages, rare polymorphic neutro-
phils and lymphocytes, and mucoid material in the background.
The cytologic diagnosis was reported as benign cytologic ﬁndings.
On PET CT there was a dense hypermetabolic mass lesion in the
right middle lobe lateral segment, suggesting a malignancy (SUV
max: 3.9). Since the patient was a smoker, this lesion was primarily
considered as a second primary or the lung metastasis of another
malignancy. (Fig. 2) The mass was also considered to be inappro-
priate for transthoracic ﬁne needle aspiration (TTFA) for technical
reasons. A wedge resection of the mass was carried out due to the
risk of pneumothorax. An intraoperative frozen section was made,
and did not reveal any malignancy. Therefore no further treatment
was applied. Macroscopic examination reported a nodular lesion in
the lung parenchyma, with regular borders and measuring 1.7 cm.
The mass appeared elastic, yellow-gray colored, and homogenous
on sectioning. Three millimeter thick sections were harvested from
the lesion and embedded into parafﬁn blocks after routine tissue
procedures.
The material was examined under light microscopy. Sections
showed a storiform or fascicular pattern tumor. Tumor elements
consisted of cells with eosinophilic cytoplasm, oval and spindle
Fig. 1. Computer tomography image shows a mass measuring 1.9 cm and located in
the lateral segment of the right middle lobe.
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nucleoli. There was no cytologic atypia or mitosis. Lymphocytes,
plasma cells, and histiocytes were occasionally present. Immuno-
histochemical studies showed focal positivity for SMA (smooth
muscle actin), and there was no staining with antibodies against
CD34, CD99, S100, and pancytokeratin. The Ki-67 proliferation in-
dex (1%) was low (Figs. 3e9). The pathologic diagnosis was in-
ﬂammatory myoﬁbroblastic tumor. The patient did not receive any
postoperative treatment, and is currently asymptomatic on the
postoperative third year.
3. Discussion
IMT is a rare lung disease. The lesion consists of a variable
mixture of inﬂammatory and mesenchymal cells that includes in-
ﬂammatory pseudotumor plasma cells, histiocytes, lymphocytes,
and ﬁbroblasts. It can occur in numerous locations throughout the
body, however the most common location is the lung.4 Most of the
reported cases are between 27 and 50 years of age, and under 40.5
Both sexes are affected equally, and no geographic or ethnic pre-
disposition has been reported.6 Our patient was a 50 year old fe-
male living in the mediterranean area.Fig. 2. PET CT shows a mass in the lateral segment of the right middle lobe, showing
a malignant character with SUV max: 3.9.
Fig. 3. (a): Storiform and fascicular pattern tumor separated from the lung tissue by
smooth borders (H&Ex100). (b): Tumor cells with eosinophilic cytoplasm, oval and
spindle shaped nuclei, thin chromatin distribution, and accompanied by lymphocytes,
plasma cells and histiocytes in between (H&Ex200). (c): Tumor elements without
cytologic atypia or mitotic ﬁgures, and inﬂammatory cells. (H&Ex400).The frequency of this lesion in the lung is 0.04e1.0% among the
general population.7,8 Approximately half of the patients are
asymptomatic, whereas 26e56% of the patients have symptoms
including cough, hemoptysis, dyspnea and chest pain. The mass
lesion is discovered incidentally in chest x rays.8 Our patient
was asymptomatic and the mass was discovered during tumor
surveillance.
The radiologic ﬁndings of IMT were analyzed by Agrons et al.5
Thoracic CT reveals a single nodule and mass in 90% of these
Fig. 4. cd34 staining revealed that the internal control (vascular structures) was
positive, whereas the tumor did not show staining. (IHK-cd34x200).
Fig. 5. Positive staining of tumor elements with sma. (IHK-smaX200).
Fig. 7. Pan-ck staining showed that the internal control (bronchial epithelium) was
positive, whereas the tumor did not show staining. (IHK pan-ckx100).
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hilus, mediastinum and airways were reported in 16% of the pa-
tients. The lesion in our patient was also a single nodule detected in
chest CT. PET CT is often positive in these cases.9 Our patient had
FDG uptake in PET CT.Fig. 6. s100 staining revealed that the internal control (cross section of a peripheral
nerve is marked in the lower right) was positive whereas the tumor did not show
staining. (IHK-s100x100).It is difﬁcult to make a diagnosis by bronchoscopic biopsy and
transthoracic needle aspiration. Therefore, open lung biopsy or
videothoracoscopic resection is often necessary.7e10 The diagnosis
was made after thoracoscopic wedge resection in our patient.
Matsubara et al. categorized inﬂammatory pseudotumor into
three groups based on cellular types and main histologic prop-
erties: A) Organized pneumonia formed by gradual healing of the
intraalveolar exudation (44%), B) Fibrous histiocytoma formed by
storiform proliferation of plasmocyte and lymphocyte aggregates
(44%), and C) lymphoplasmocytic type formed by the aggregation
of both plasmocyte and lymphocytes (12%).8 A storiform or fas-
cicular pattern tumor was observed in our case. The cells con-
stituting the tumor elements had an eosinophilic cytoplasm, oval,
spindle shaped nuclei with thin chromatin dispertion, and with
indistinct nucleoli. There was no cytologic atypia or mitosis. There
were also lymphocytes, plasma cells and histiocytes.
The treatment of pulmonary IMT is surgical.3e11 Recurrences are
rare after complete resection.12,13 The results are also generally well
in patients who undergo radical resection.3e11 However, re-
currences can still occur years after resection,2e14 and deaths
related to IMT are reported.2e15 The recurrences are caused by
incomplete resection.7 Since there were no endobronchial lesions
in our patient, a parenchyma preserving surgery was preferred andFig. 8. The external control is positive with cd99, and the tumor is negative.
(IHK-cd99x200).
Fig. 9. Scarce nuclear positivity in tumor elements with ki-67. (IHK-ki-67 x400).
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currences during the three year follow up.
4. Conclusion
Although IMT is rare, it should be considered in the differential
diagnosis of lung lesions. It is generally a benign lesion, however it
has potential for local invasion and recurrence. The diagnosis and
prognosis depend on complete resection.
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